Book of Abstracts - Ruhr-Universität Bochum
Book of Abstracts - Ruhr-Universität Bochum
Book of Abstracts - Ruhr-Universität Bochum
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
OP-16<br />
Ru<br />
N<br />
Cl Cl<br />
N<br />
Ru<br />
Cl Cl<br />
ISBOMC `10 5.7 – 9.7. 2010 <strong>Ruhr</strong>-<strong>Universität</strong> <strong>Bochum</strong><br />
Anticancer Activity <strong>of</strong> Multinuclear Ruthenium-Arene Complexes Coordinated<br />
to Dendritic Poly(propyleneimine) Scaffolds<br />
R<br />
R<br />
O<br />
N<br />
R<br />
Cl<br />
Ru Cl<br />
N<br />
N<br />
Ru Cl<br />
O<br />
Cl<br />
N<br />
R<br />
N<br />
R<br />
N<br />
Cl<br />
Cl<br />
N<br />
Ru<br />
N<br />
Cl<br />
Cl<br />
R<br />
Gregory S. Smith *a and P. Govender a<br />
a University <strong>of</strong> Cape Town, Faculty <strong>of</strong> Science, Department <strong>of</strong> Chemistry, 7701, Cape Town,<br />
South Africa. E-mail: Gregory.Smith@uct.ac.za<br />
Dendrimers have found potential as molecular tools in biological applications, especially as nanocarriers,<br />
diagnostic agents and as chemotherapeutics. 1-4 An advantage <strong>of</strong> using dendrimers is their<br />
multivalency, which leads to increased interaction between a dendrimer-drug conjugate and a target<br />
bearing multiple receptors, further improving the selectivity to cancer cells. Large macromolecules,<br />
like dendrimers, can also specifically target tumours by exploiting the ‘enhanced permeability and<br />
retention’ (EPR) effect, in which macromolecules can accumulate at the tumour site due to an increase<br />
in blood vessel permeability within diseased tissues compared to normal tissues. 5<br />
In this presentation, we report a series <strong>of</strong> multinuclear ruthenium-arene complexes based on first- and<br />
second-generation poly(propyleneimine) dendritic scaffolds (Fig. 1). Their cytotoxicity against the<br />
A2780 human ovarian cancer cell line will also be discussed.<br />
O<br />
N<br />
Ru<br />
N<br />
O<br />
N<br />
Cl Cl<br />
Ru<br />
N<br />
Cl Cl<br />
N<br />
Ru<br />
N<br />
32<br />
R<br />
R<br />
Cl Cl<br />
N Ru<br />
N<br />
R<br />
R<br />
N<br />
N Ru<br />
Cl Cl<br />
=<br />
N<br />
R<br />
R<br />
N<br />
Ru N<br />
N<br />
Cl Cl<br />
R<br />
N<br />
Ru N<br />
Cl Cl<br />
Fig. 1: Ruthenium-arene metallodendrimers based on a poly(propyleneimine) scaffold.<br />
References<br />
1. (a) U. Boas, J. B. Christensen, P. M. H. Heegaard: Dendrimers in Medicine and Biotechnology:<br />
New Molecular Tools, RSC Publishing (2006). (b) C. C. Lee, J. A. MacKay, J. M. J. Fréchet, F. C.<br />
Szoka, Nature Biotech. 2005, 23, 1517-1526.<br />
2. F. Aulenta, W. Hayes, S. Rannard, Eur. Polym. J. 2003, 39, 1741-1771 and references therein.<br />
3. J. B. Wolinsky, M. W. Grinstaff, Adv. Drug Deliv. Rev. 2008, 60, 1037-1055 and references therein.<br />
4. (a) A. Agarwal, S. Saraf, A. Asthana, U. Gupta, V. Gajbhiye, N. K. Jain, Int. J. Pharm. 2008, 350,<br />
3-13. (b) E. R. Gillies, J. M. J. Fréchet, Drug Discov. Today 2005, 10, 35- 43.<br />
5. D.F. Baban, L.W. Seymour, Adv. Drug Delivery Rev. 1998, 34, 109-119.<br />
4+<br />
O<br />
O H